D+19
Today is 2022. 10. 03

Scientific Program

  • Home
  • Program
  • Scientific Program

※Some lectures will be pre-recorded.

September 15(Thu)
12:50 - 14:20
Symposium 1
Optimal risk factor control in patients with DM
September 15(Thu) 12:50 - 14:20
Symposium 1
Optimal risk factor control in patients with DM

Chairpersons

우정택 (경희의대), 홍영준 (전남의대)

Panels

강신애 (연세의대), 최익준 (가톨릭의대)

12:50 - 13:10

How much treatable residual risk do we really have?

구보경 (서울의대)

13:10 - 13:30

Concept of multiple risk factor control in DM

김현민 (중앙의대)

13:30 - 13:50

Is there special tool for control of diabetic dyslipidemia?

김남훈 (고려의대)

13:50 - 14:15

Discussion

September 15(Thu)
15:30 - 17:00
Symposium 4
Update on coronary CT: risk marker, monitoring tool & future perspective
September 15(Thu) 15:30 - 17:00
Symposium 4
Update on coronary CT: risk marker, monitoring tool & future perspective

Chairperson

박철영 (성균관의대)

Panels

전은주 (서울의대), 최철웅 (고려의대)

15:30 - 15:50

Calcium score to predict future CV event

이은정 (성균관의대)

15:50 - 16:10

What are unsolved issues in the coronary CT research?

조익성 (연세의대)

16:10 - 16:30

New markers of coronary CT for future CV event

차민재 (중앙의대)

16:30 - 16:55

Discussion

Breakfast & Luncheon Symposium
September 15(Thu)
12:00 - 12:50
Luncheon Symposium 1 [Daewoong]
September 15(Thu) 12:00 - 12:50
Luncheon Symposium 1 [Daewoong]

Chairperson

최동훈 (연세의대)

Panels

문재연 (차의대), 문준성 (영남의대)

12:00 - 12:20

Atorvastatin with ezetimibe combination therapy for very high/high risk groups

이승표 (서울의대)

12:20 - 12:30

Discussion

September 15(Thu)
12:50 - 14:20
Basic Research Workshop 1
Lipid metabolism & metabolic disorders
September 15(Thu) 10:00 - 10:50
Basic Research Workshop 1 Lipid metabolism & metabolic disorders

Chairperson

Young Mi Park (Ewha Womans University, Korea)

Panels

Hyun Duk Jang (Seoul National University, Korea), Kyung-Sun Heo (Chungnam National University, Korea)

12:50 - 13:10

Cellular lipid trafficking & cholesterol homeostasis

Young Mi Park (Ewha Womans University, Korea)

13:10 - 13:30

Identification of novel lipid droplet factors in macrophage foam cells

Mireille Ouimet (University of Ottawa, Canada)

13:30 - 13:50

Nutrient sensing mechanism for LDLR related protein LRP6

Eek-hoon Jho (University of Seoul, Korea)

13:50 - 14:15

Discussion

September 15(Thu)
14:30 - 15:30
Oral Presentation 1 (APSAVD Young Investigator Session)
September 15(Thu) 14:30 - 15:30
Oral Presentation 1 (APSAVD Young Investigator Session)

Chairpersons

Chul-Ung Choi (Korea University, Korea), Edward Janus (University of Melbourne, Australia)

Panels

Jun Sung Moon (Yeungnam University, Korea), Sangmo Hong (Hanyang University, Korea)

14:30 - 14:37

A novel molecular diagnostic prototype for detection of pathogenic familial hypercholesterolaemia variants in an Asian population

Norhidayah Rosman (AIMST University, Malaysia)

14:37 - 14:44

Apolipoprotein CIII deficiency exacerbates diet-induced fatty liver & insulin resistance in knock-out rabbits

Xiangming Tang (University of Yamanashi, Japan)

14:44 - 14:51

PCSK9 inhibitors exhibit attenuation of biomarkers of endothelial activation & oxidative stress in human coronary artery endothelial cells

Rahayu Zulkapli (Universiti Teknologi MARA, Malaysia)

14:51 - 14:58

Comparison of on-statin lipid & lipoprotein levels for residual cardiovascular risk prediction in type 2 diabetes

Ji Yoon Kim (Korea University, Korea)

14:58 - 15:23

Q&A

September 15(Thu)
15:30 - 17:00
Basic Research Workshop 2
SMC plasticity in plaque stability
September 15(Thu) 15:30 - 17:00
Basic Research Workshop 2 SMC plasticity in plaque stability

Chairperson

김재룡 (영남대)

Panels

김용숙 (전남의대),임소연 (가톨릭관동대)

15:30 - 15:50

Role of TCF21 disease gene in SMC phenotype modulation

Juyong Brian Kim (Stanford University, USA)

15:50 - 16:10

Targeting SMC phenotypic switching in vascular disease

명창선 (충남대)

16:10 - 16:30

Regulation of phenotypic plasticity of vascular smooth muscle cells

배순식 (부산대)

16:30 - 16:55

Discussion

Breakfast & Luncheon Symposium
September 15(Thu)
12:00 - 12:50
Luncheon Symposium 2 [Chong Kun Dang]
September 15(Thu) 12:00 - 12:50
Luncheon Symposium 2 [Chong Kun Dang]

Chairperson

Jaetaek Kim (Chung-Ang University, Korea)

Panels

Ji Woong Roh (Yonsei University, Korea), Sangmo Hong (Hanyang University, Korea)

12:00 - 12:20

How to manage cardiovascular health with atorvastation in patients

Hyungdon Kook (Hanyang University, Korea)

12:20 - 12:30

Discussion

September 15(Thu)
12:50 - 14:20
Symposium 2
Novel risk factors & intervention targets in atherosclerosis
September 15(Thu) 12:50 - 14:20
Symposium 2 Novel risk factors & intervention targets in atherosclerosis

Chairpersons

Moon-Kyu Lee (Eulji University, Korea), Mahmood Hussain (New York University, USA)

Panels

Yoo-wook Kwon (Seoul National University, Korea), Jong-Chan Youn (The Catholic University of Korea, Korea)

12:50 - 13:10

Biological & clinical influence of air pollution on metabolism & vasculature

Seung-Pyo Lee (Seoul National University, Korea)

13:10 - 13:30

Role of T-cell cholesterol efflux pathways in aging, inflammation, & atherosclerosis

Marit Westerterp (University of Groningen, Netherlands)

13:30 - 13:50

Circadian rhythm as risk & treatment target in ASCVD

Mahmood Hussain (New York University, USA)

13:50 - 14:15

Discussion

September 15(Thu)
12:50 - 14:20
Symposium 3
NAFLD, metabolic dysfunction & ASCVD
September 15(Thu) 12:50 - 14:20
Symposium 3 NAFLD, metabolic dysfunction & ASCVD

Chairpersons

Youngmi Kim (Kyung Hee University, Korea), Byung Wan Lee (Yonsei University, Korea)

Panels

Chang-Yeon Kim (Daegu Catholic University, Korea), Hye-Jin Yoo (Korea University, Korea)

12:50 - 13:10

MAFLD & risk of cardiovascular disease

Yong-ho Lee (Yonsei University, Korea)

13:10 - 13:30

The role of mitochondrial enzyme PDK in the pathogenesis of NAFLD & ASCVD

Jae-Han Jeon (Kyungpook National University, Korea)

13:30 - 13:50

Recent evidence between CVD & NAFLD/NASH in Japan

Masahiro Koseki (Osaka University, Japan)

13:50 - 14:15

Discussion

September 15(Thu)
15:30 - 17:00
Symposium 5
Lipid as risk & target in cerebrovascular disease
September 15(Thu) 15:30 - 17:00
Symposium 5 Lipid as risk & target in cerebrovascular disease

Chairpersons

Sun U. Kwon (University of Ulsan, Korea), Sang-Ho Jo (Hallym University, Korea)

Panels

Jeong-Min Kim (Seoul National University, Korea), Hoyoun Won (Chung-Ang University, Korea)

15:30 - 15:50

Lipid management for patients with non-atherosclerotic stroke

Woo-Keun Seo (Sungkyunkwan University, Korea)

15:50 - 16:10

Target LDL-C level for patients with cerebrovascular disease

Kazuo Kitagawa (Tokyo women's medical hospital, Japan)

16:10 - 16:30

The next step in stroke prevention: beyond lowering LDL cholesterol

Yong-Jae Kim (The Catholic University of Korea, Korea)

16:30 - 16:55

Discussion

September 16(Fri)
09:00 - 09:40
Plenary Lecture 1
September 16(Fri) 09:00 - 09:40
Plenary Lecture 1

Chairperson

Donghoon Choi (Yonsei University, Korea)

09:00 - 09:40

Target discovery & drug development for atherosclerosis in 2020's

Sekar Kathiresan (Verve therapeutics, USA)

September 16(Fri)
09:45 - 11:15
Symposium 6
Adipose tissue & atherosclerosis
September 16(Fri) 09:45 - 11:15
Symposium 6 Adipose tissue & atherosclerosis

Chairpersons

한진 (인제의대), 노정현 (인제의대)

Panels

김남훈 (고려의대), 전성완 (순천향의대)

09:45 - 10:05

Novel mechanisms for lipogenesis regulation

Gina Lee (University of California Irvine, USA)

10:05 - 10:25

Local & systemic effect of organ fat deposition

최성희 (서울의대)

10:25 - 10:45

Sex-dependent NAD+ metabolism in the liver & adipose tissue

Ji-Young Lee (University of Connecticut, USA)

10:45 - 11:10

Discussion

September 16(Fri)
11:30 - 12:00
Plenary Lecture 2 (APSAVD:Ding Lecture)
September 16(Fri) 11:30 - 12:00
Plenary Lecture 2 (APSAVD:Ding Lecture)

Chairperson

Richard O’Brien (University of Melbourne, Australia)

11:30 - 12:00

Recent developments in the treatment of familial hypercholesterolaemia & other familial lipid disorders

Brian Tomlinson (Macau University of Science & Technology, China)

September 16(Fri)
12:55 - 13:35
Plenary Lecture 3
September 16(Fri) 12:55 - 13:35
Plenary Lecture 3

Chairperson

Goo Taeg Oh (Ewha Womans University, Korea)

12:55 - 13:35

Senescence & vascular smooth muscle cell plasticity

Martin Bennett (University of Cambridge, UK)

September 16(Fri)
13:35 - 15:05
Symposium 10
Debate on developing risk grouping in Korea: current status, comparison with foreign, & solution
September 16(Fri) 13:35 - 15:05
Symposium 10 Debate on developing risk grouping in Korea: current status, comparison with foreign, & solution

Chairpersons

정명호 (전남의대), 김성래 (가톨릭의대)

Panels

김경수 (차의대), 박재형 (고려의대)

13:35 - 13:55

Current evidence on risk stratifying factors in Koreans

허지혜 (한림의대)

13:55 - 14:15

How much different event risk do Koreans have compared to European descendants?

안성복 (이화의대)

14:15 - 14:35

How to select of low risk individuals to avoid pharmacotherapy?

김학령 (서울의대)

14:35 - 15:00

Discussion

September 16(Fri)
15:15 - 16:15
Oral Presentation 2
September 16(Fri) 15:15 - 16:15
Oral Presentation 2

Chairperson

권유욱 (서울대)

Panels

조아현 (가톨릭의대), 홍준화 (을지의대)

15:15 - 15:22

Prediction of future vascular events from thrombus analysis of Ischemic myopathy (TAOISM)

김정민 (서울의대)

15:22 - 15:29

Comparison of single-pill combination of moderate-intensity rosuvastatin & ezetimibe versus high-intensity rosuvastatin in atherosclerotic cardiovascular disease patients with type 2 diabetes

최효인 (성균관의대)

15:29 - 15:36

Protocatechuic acid prevents heart failure in isoproterenol-infused mice by downregulating Kmo

기해진 (전남의대)

15:36 - 15:43

Rh1 ginsenoside suppressed lipopolysaccharide-induced endothelial cell inflammation & apoptosis by inhibiting endoplasmic reticulum stress & TLR4-mediated STAT3/NF-kB pathway

진유진 (충남대)

15:43 - 16:08

Q&A

September 16(Fri)
16:15 - 17:45
Symposium 13
Debate on new Korean guidelines on dyslipidemia: treatment
September 16(Fri) 16:15 - 17:45
Symposium 13 Debate on new Korean guidelines on dyslipidemia: treatment

Chairpersons

김치정 (중앙의대), 장학철 (서울의대)

Panels

김병진 (성균관의대), 정인경 (경희의대)

16:15 - 16:35

Korean evidence on target LDL-C levels

문민경 (서울의대)

16:35 - 16:55

Are current Western LDL-C targets for each risk groups cost-effective in Koreans?

김상현 (서울의대)

16:55 - 17:15

When is clinically appropriate to start anti-PCSK9 Abs?

남창욱 (계명대)

17:15 - 17:40

Discussion

Breakfast & Luncheon Symposium
September 16(Fri)
08:00 - 09:00
Breakfast Symposium 1 [Celltrionpharm]
September 16(Fri) 08:00 - 09:00
Breakfast Symposium 1 [Celltrionpharm]

Chairperson

이우제 (울산의대)

Panels

서지아 (고려의대), 장지용 (연세의대)

08:00 - 08:20

Pioglitazone & Cardiovascular Risk Reduction

노정현 (인제의대)

08:20 - 08:30

Discussion

September 16(Fri)
12:00 - 12:50
Luncheon Symposium 3 [Organon]
September 16(Fri) 12:00 - 12:50
Luncheon Symposium 3 [Organon]

Chairperson

이홍규 (서울의대)

Panels

윤혁준 (계명의대), 한승진 (아주의대)

12:00 - 12:20

Recent Update on Combination Therapy for High risk ASCVD patients

윤종찬 (가톨릭의대)

12:20 - 12:30

Discussion

September 16(Fri)
09:00 - 09:40
Plenary Lecture 1
September 16(Fri) 09:00 - 09:40
Plenary Lecture 1

Chairperson

Donghoon Choi (Yonsei University, Korea)

09:00 - 09:40

Target discovery & drug development for atherosclerosis in 2020's

Sekar Kathiresan (Verve therapeutics, USA)

September 16(Fri)
09:45 - 11:15
Symposium 7
New regulators of dyslipidemia & atherosclerosis
September 16(Fri) 09:45 - 11:15
Symposium 7 New regulators of dyslipidemia & atherosclerosis

Chairpersons

In Kyeom Kim (Kyungpook National University, Korea), Soon Jun Hong (Korea University, Korea)

Panels

Eun Hee Koh (University of Ulsan, Korea), Pilhan Kim (KAIST, Korea)

09:45 - 10:05

Validation of metabolic targets in adipose tissue for ASCVD

Mete Civelek (University of Virginia, USA)

10:05 - 10:25

Deficiency of myeloid PHD proteins aggravates atherogenesis via macrophage apoptosis & paracrine fibrotic signalling

Judith Sluimer (Maastricht University, Netherlands)

10:25 - 10:45

Understanding the phenotypic changes of vascular smooth muscle cells during atherosclerosis

Jae-Hoon Choi (Hanyang University, Korea)

10:45 - 11:10

Discussion

September 16(Fri)
11:30 - 12:00
Plenary Lecture 2 (APSAVD:Ding Lecture)
September 16(Fri) 11:30 - 12:00
Plenary Lecture 2 (APSAVD:Ding Lecture)

Chairperson

Richard O’Brien (University of Melbourne, Australia)

11:30 - 12:00

Recent developments in the treatment of familial hypercholesterolaemia & other familial lipid disorders

Brian Tomlinson (Macau University of Science & Technology, China)

September 16(Fri)
12:55 - 13:35
Plenary Lecture 3
September 16(Fri) 12:55 - 13:35
Plenary Lecture 3

Chairperson

Goo Taeg Oh (Ewha Womans University, Korea)

12:55 - 13:35

Senescence & vascular smooth muscle cell plasticity

Martin Bennett (University of Cambridge, UK)

September 16(Fri)
13:35 - 15:05
Food & Nutrition Workshop
Cardiometabolic disease & customized nutrition management
September 16(Fri) 13:35 - 15:05
Food & Nutrition Workshop Cardiometabolic disease & customized nutrition management

Chairpersons

이명숙 (성신여대), 정효지 (서울대)

Panels

서존 (순천향의대), 임현정 (경희대)

13:35 - 13:55

Customized functional food based on big data

김지영 (서울대)

13:55 - 14:15

Customized prevention of metabolic disease in Koreans using omics technology

김민주 (한남대)

14:15 - 14:35

Healthcare program using digital health device

김영인 (주식회사 가지랩)

14:35 - 15:00

Discussion

September 16(Fri)
15:15 - 16:15
Oral Presentation 3
September 16(Fri) 15:15 - 16:15
Oral Presentation 3

Chairpersons

Hyuk-Sang Kwon (The Catholic University of Korea, Korea), Sungha Park (Yonsei University, Korea)

Panels

Hyun Min Kim (Chung-Ang University, Korea), Su Jin Jeong (Sejong General Hospital, Korea)

15:15 - 15:22

Cardiovascular risk factor profiles of familial hypercholesterolaemia patients with & without pathogenic FH candidate gene variants in the Malaysian community

Aimi Zafira Razman (Universiti Teknologi MARA, Malaysia)

15:22 - 15:29

Impact of genetic testing on low-density lipoprotein cholesterol in patients with familial hypercholesterolemia (GenTLe-FH): a randomized waiting list controlled open-label trial

Akihiro Nomura (Kanazawa University, Japen)

15:29 - 15:36

Dyslipidemia & type 2 diabetes among Filipino adults

Cherry Ann Durante (Emilio Aguinaldo College Manila, Philippines)

15:36 - 15:43

The relationship between total cholesterol level & oxidative stress in the liver tissue of the hyperlipidemic rat model after the intervention with synbiotic beverage

Rafik Prabowo (Universitas Islam Indonesia, Indonesia)

15:43 - 15:50

Determination of pathogenicity in ABCG5 & ABCG8 gene among Japanese dyslipidemic patients

Nobuko Kojima (Kanazawa University, Japan)

15:50 - 16:15

Q&A

September 16(Fri)
16:15 - 17:45
Publication Committee Symposium
September 16(Fri) 16:15 - 17:45
Publication Committee Symposium

Chairpersons

박용식 (경희대), 김정민 (서울의대)

16:15 - 16:20

JLA Award Ceremony

16:20 - 16:35

Regulation of macrophage activation & differentiation in atherosclerosis

박성호 (유니스트)

16:35 - 16:50

Prospect of artificial intelligence based on electronic medical records

김헌성 (가톨릭의대)

16:50 - 17:05

Intravital two-photon imaging of dynamic alteration of lipid droplet in a live animal model

김필한 (카이스트)

17:05 - 17:20

Statin therapy & the risk of osteoporotic fractures in patients with metabolic syndrome: a nested case-control study

김경진 (고려의대)

17:20 - 17:35

Metabolism & health impacts of dietary sugars

Cholsoon Jang (University of California Irvine, USA)

17:35 - 17:45

Q&A

Breakfast & Luncheon Symposium
September 16(Fri)
08:00 - 09:00
Breakfast Symposium 2 [Organon]
September 16(Fri) 08:00 - 09:00
Breakfast Symposium 2 [Organon]

Chairperson

Seonghoon Choi (Hallym University, Korea)

Panels

Bo Kyung Koo (Seoul National University, Korea), Hyemoon Chung (Kyung Hee University, Korea)

08:00 - 08:20

Management of uric acid in hypertensive patients: role of losartan

Hack-Lyoung Kim (Seoul National University, Korea)

08:20 - 08:30

Discussion

September 16(Fri)
12:00 - 12:50
Luncheon Symposium 4 [JW Pharmaceutical]
September 16(Fri) 12:00 - 12:50
Luncheon Symposium 4 [JW Pharmaceutical]

Chairperson

Jeong Euy Park (Sungkyunkwan University, Korea)

Panels

Bong-Ki Lee (Kangwon National University, Korea), Suk Chon (Kyung Hee University, Korea)

12:00 - 12:20

Cutting edge care of Pitavastatin with Ezetimibe combination therapy

Jun Hwa Hong (Eulji University, Korea)

12:20 - 12:30

Discussion

September 16(Fri)
09:00 - 09:40
Plenary Lecture 1
September 16(Fri) 09:00 - 09:40
Plenary Lecture 1

Chairperson

Donghoon Choi (Yonsei University, Korea)

09:00 - 09:40

Target discovery & drug development for atherosclerosis in 2020's

Sekar Kathiresan (Verve therapeutics, USA)

September 16(Fri)
09:45 - 11:15
Symposium 8
High CV risk group: is it properly defined?
September 16(Fri) 09:45 - 11:15
Symposium 8 High CV risk group: is it properly defined?

Chairpersons

Myung-A Kim (Seoul National University, Korea), Woo Je Lee (University of Ulsan, Korea)

Panels

Hack-Lyoung Kim (Seoul National University, Korea), Jung-Joon Cha (Korea University, Korea)

09:45 - 10:05

What is the role of a polygenic risk score in CV risk assessment?

Amit Khera (Verve Therapeutics, USA)

10:05 - 10:25

Refinement of CV risk in current "very high" & "high" risk groups

Hyeon Chang Kim (Yonsei University, Korea)

10:25 - 10:45

Risk stratification according to age groups in new prevention guidelines

Kwang-il Kim (Seoul National University, Korea)

10:45 - 11:10

Discussion

September 16(Fri)
11:30 - 12:00
Plenary Lecture 2 (APSAVD:Ding Lecture)
September 16(Fri) 11:30 - 12:00
Plenary Lecture 2 (APSAVD:Ding Lecture)

Chairperson

Richard O’Brien (University of Melbourne, Australia)

11:30 - 12:00

Recent developments in the treatment of familial hypercholesterolaemia & other familial lipid disorders

Brian Tomlinson (Macau University of Science & Technology, China)

September 16(Fri)
12:55 - 13:35
Plenary Lecture 3
September 16(Fri) 12:55 - 13:35
Plenary Lecture 3

Chairperson

Goo Taeg Oh (Ewha Womans University, Korea)

12:55 - 13:35

Senescence & vascular smooth muscle cell plasticity

Martin Bennett (University of Cambridge, UK)

September 16(Fri)
13:35 - 15:05
Symposium 11
Inflammation in progression & inhibition of atherosclerosis
September 16(Fri) 13:35 - 15:05
Symposium 11 Inflammation in progression & inhibition of atherosclerosis

Chairpersons

Hyo-Soo Kim (Seoul National University, Korea), Young-Guen Kwon (Yonsei University, Korea)

Panels

Young-Kook Kim (Chonnam National University, Korea), Chang Hee Jung (University of Ulsan, Korea)

13:35 - 13:55

Macrophage diversity in inflammation & homeostasis

Ichiro Manabe (Chiba University, Japan)

13:55 - 14:15

Inflammation & hematopoiesis in atherosclerosis

Katey Rayner (University of Ottawa, Canada)

14:15 - 14:35

Immune cell repertoire & novel therapeutic target of aortic aneurysm

Seung-Jun Lee (Yonsei University, Korea)

14:35 - 15:00

Discussion

September 16(Fri)
15:15 - 16:15
2022 KSoLA Awards for Scientific Excellence & Young Investigator
Scientific Excellence Award Lecture
September 16(Fri) 15:15 - 16:15
2022 KSoLA Awards for Scientific Excellence & Young Investigator
Scientific Excellence Award Lecture

Chairpersons

Myung A Kim (Seoul National University, Korea), Donghoon Choi (Yonsei University, Korea)

15:15 - 15:20

2022 KSoLA Awards Ceremony for Scientific Excellence & Young Investigator

15:20 - 15:40

TG lowering: Hope vs. Hype?

Sang-Ho Jo (Hallym University, Korea)

15:40 - 15:45

Q&A

September 16(Fri)
16:15 - 17:45
Symposium 14 (JAS/KSoLA Joint Symposium)
Impact of aging of vascular cells on atherosclerosis & its protection
September 16(Fri) 16:15 - 17:45
Symposium 14 (JAS/KSoLA Joint Symposium) Impact of aging of vascular cells on atherosclerosis & its protection

Chairperson

Sang Hong Baek (The Catholic University of Korea, Korea)

Panels

Kwang-il Kim (Seoul National University, Korea), Kyu-Tae Kim (Ajou University, Korea)

16:15 - 16:35

Aging as risk factor & therapeutic target in atherosclerosis

Sungha Park (Yonsei University, Korea)

16:35 - 16:55

New target genes & molecules for vascular aging

Tohru Minamino (Juntendo University, Japan)

16:55 - 17:15

What effect do cardiovascular medications & diet have on vascular aging?

Kenichi Tsujita (Kumamoto University, Japan)

17:15 - 17:40

Discussion

Breakfast & Luncheon Symposium
September 16(Fri)
12:00 - 12:50
Luncheon Symposium 5 [Viatris]
September 16(Fri) 12:00 - 12:50
Luncheon Symposium 5 [Viatris]

Chairperson

Hyun Ho Shin (Asan Chungmu Hospital, Korea)

Panels

Jae-seung Yun (The Catholic University of Korea, Korea), Jun Won Lee (Yonsei University, Korea)

12:00 - 12:20

What are the optimal treatment options of dyslipidemia management for your
patients? based on LDL-C lowering continuum

So-Yeon Choi (Ajou University, Korea)

12:20 - 12:30

Discussion

September 16(Fri)
09:45 - 11:15
Symposium 9
Update on non-pharmacological control of ASCVD risk
September 16(Fri) 09:45 - 11:15
Symposium 9
Update on non-pharmacological control of ASCVD risk

Chairpersons

Ick Mo Chung (Ewha Womans University , Korea), Sung Nim Han (Seoul National University, Korea)

Panels

Oh Yoen Kim (Dong-A University, Korea), Yeon-Kyung Choi (Kyungpook National University, Korea)

09:45 - 10:05

Exercise & inflammation in atherosclerosis

Matthias Nahrendorf (Harvard Medical School, USA)

10:05 - 10:25

Effect of different diets on circulating lipoproteins

Frank Sacks (Harvard Medical School, USA)

10:25 - 10:45

Trends in dietary quality & cardiometabolic risks among Korean adults

Min-Jeong Shin (Korea University, Korea)

10:45 - 11:10

Discussion

September 16(Fri)
13:35 - 15:05
Symposium 12 (IAS/APSAVD/JAS Joint Symposium)
Dyslipidaemia
September 16(Fri) 13:35 - 15:05
Symposium 12 (IAS/APSAVD/JAS Joint Symposium)
Dyslipidaemia

Chairpersons

Jaetaek Kim (Chung-Ang University, Korea), Richard O’Brien (University of Melbourne, Australia)

Panels

Jae Hyuk Lee (Myongji Hospital, Korea), Seung Jin Han (Ajou University, Korea)

13:35 - 13:55

Dyslipidaemia - new treatments for ApoC3 & ANGPTL3

Brian Tomlinson (Macau University of Science & Technology, China)

13:55 - 14:15

Novel selective PPARa modulator pemafibrate for dyslipidemia & nonalcoholic fatty liver disease (NAFLD)

Shizuya Yamashita (Rinku General Medical Center, Japan)

14:15 - 14:45

New treatment targets beyond LDL-C in dyslipidaemias

Alberico Catapano (University of Milan, Italy)

14:45 - 15:05

Discussion

September 16(Fri)
16:15 - 17:45
Symposium 15 (APSAVD/KSoLA Joint Symposium)
COVID-19 & cardiovascular risk
September 16(Fri) 16:15 - 17:45
Symposium 15 (APSAVD/KSoLA Joint Symposium)
COVID-19 & cardiovascular risk

Chairpersons

Young-Bae Park (Seoul National University, Korea), Edward Janus (University of Melbourne, Australia)

Panels

Hong Nyun Kim (Kyungpook National University, Korea), Jung Ho Heo (Kosin University, Korea)

16:15 - 16:35

Impact of risk factors & medications on COVID-19 outcomes

In Sook Kang (Ewha Womans University, Korea)

16:35 - 16:55

Effect of COVID-19 on dyslipidemia & vascular disease

Edward Janus (University of Melbourne, Australia)

16:55 - 17:15

Benefit & harm of COVID-19 vaccines in ASCVD

Ta-Chen Su (National Taiwan University, Taiwan)

17:15 - 17:40

Discussion

Breakfast & Luncheon Symposium
September 16(Fri)
12:00 - 12:50
Luncheon Symposium 6 [Boehringer Ingelheim/Lilly]
September 16(Fri) 12:00 - 12:50
Luncheon Symposium 6 [Boehringer Ingelheim/Lilly]

Chairperson

Shung Chull Chae (Kyungpook National University, Korea)

Panels

Hye-Mi Kim (Chung-Ang University, Korea), Yeoree Yang (The Catholic University of Korea, Korea)

12:00 - 12:20

How does empagliflozin connect to CRM : HF underappreciated complication of T2D

Sang-Hun Shin (Ewha Womans University, Korea)

12:20 - 12:30

Discussion

September 16(Fri)
15:15 - 15:55
Moderated Poster Presentation 1
September 16(Fri) 15:15 - 15:55
Moderated Poster Presentation 1

Chairperson

김소헌(인하의대)

Panels

김성애(한림의대), 이재혁(명지병원)

15:15 - 15:23

Oasl1 deficiency promotes eNOS mRNA degradation, accelerating endothelial dysfunction & atherogenesis

김태경 (이화여대)

15:23 - 15:31

Loss of myeloid-PCSK9 improves cardio-protection against acute myocardial infarction

문신혜 (이화여대)

15:31 - 15:39

Peroxiredoxin 3 preserves cardiac function by regulating mitochondrial quality control 

손성근 (이화여대)

15:39 - 15:47

HMGB1 mediates MCP-1 expression in mechanically stressed vascular smooth muscle cells

김지원 (부산대)

September 16(Fri)
15:15 - 15:55
Moderated Poster Presentation 2
September 16(Fri) 15:15 - 15:55
Moderated Poster Presentation 2

Chairperson

Ung Kim (Yeungnam University, Korea)

Panels

Yong Sook Kim (Chonnam National University, Korea), Heung Yong Jin (Jeonbuk National University, Korea)

15:15 - 15:23

Cr6 interacting factor 1 deficiency increases homocysteine production in vascular endothelial cells

Cuk Seong Kim (Chungnam National University, Korea)

15:23 - 15:31

17 β-Estradiol Increases APE1/Ref-1 Secretion in vascular endothelial cells : involvement of calcium-dependent exosome pathway

Yuran Lee (Chungnam National University, Korea)

15:31 - 15:39

PFKFB3 & its role on ECM dependent vascular inflammation

Jenita Immanuel (Inje University, Korea)

15:39 - 15:47

PCSK9 deficient heart-derived ANP promotes cardiac survival after myocardial infarction

Na Hyeon Yoon (Ewha Womans University, Korea)

September 16(Fri)
15:05 - 15:55
Moderated Poster Presentation 5 (APSAVD Young Investigator)
September 16(Fri) 15:05 - 15:55
Moderated Poster Presentation 5 (APSAVD Young Investigator)
MP5-01

Fenofibrate lowers cardiac lipid accumulation & attenuates diabetic cardiomyopathy in dbdb mice

Jiwon Park (GIST, Korea)

MP5-02

In vitro & in silico inhibition of IL-6 & NF-κB by Nigella sativa oil & thymoquinone as potential anti atherogenic agent

Al aina Yuhainis Firus Khan (Universiti Teknologi MARA, Malaysia)

MP5-03

Coronary risk factor profile amongst premature coronary artery disease patients according to different age categories

Sukma Azureen Nazli (Universiti Teknologi MARA, Malaysia)

MP5-04

Genetic variations of ABCG5 & ABCG8 genes among clinically diagnosed fh patients attending primary care clinics in Malaysia

Yung An Chua (Universiti Teknologi MARA, Malaysia)

MP5-05

Genetic landscape of pathogenic variants in familial hypercholesterolaemia candidate genes among patients attending primary care clinics in Malaysia

Nur Syahirah Shahuri (Universiti Teknologi MARA, Malaysia)

MP5-06

Prediction rate of pathogenic variants diagnosed by various diagnostic criteria among familial hypercholesterolaemic patients attending primary care clinics

Sukma Azureen Nazli (Universiti Teknologi MARA, Malaysia)

MP5-07

Pharmacologic activation of angiotensin-converting enzyme II alleviates diabetic cardiomyopathy in db/db mice by reducing reactive oxidative stress

Woo ju Jeong (GIST, Korea)

MP5-08

Body type parameters predict cerebral small vessel disease

Ki-Woong Nam (Seoul National University, Korea)

MP5-09

A comparison of statin treatment algorithms for primary prevention in statin-naive Filipino patients

Bayani Pocholo Maglinte (Cebu Velez General Hospital, the Philippines)

September 17(Sat)
09:00 - 09:40
Plenary Lecture 4
September 17(Sat) 09:00 - 09:40
Plenary Lecture 4

Chairperson

Joong-Yeol Park (University of Ulsan, Korea)

09:00 - 09:40

New look at PCSK9 metabolism & its clinical implication

Sergio Fazio (Regeneron Pharmaceuticals, USA)

September 17(Sat)
09:45 - 11:15
Symposium 16
Current issues in severe dyslipidemia
September 17(Sat) 09:45 - 11:15
Symposium 16 Current issues in severe dyslipidemia

Chairpersons

최경묵 (고려의대), 강현재 (서울의대)

Panels

곽수헌 (서울의대), 변영섭 (인제의대)

09:45 - 10:05

What is currently best & changing in treatment of adults with FH?

이원재 (서울의대)

10:05 - 10:25

Update on familial vs multifactorial chylomicronemia syndrome

진흥용 (전북의대)

10:25 - 10:45

Understanding role of ANGPTL3 & neighbor molecules

박훈준 (가톨릭의대)

10:45 - 11:10

Discussion

September 17(Sat)
11:25 - 12:05
Plenary Lecture 5
September 17(Sat) 11:25 - 12:05
Plenary Lecture 5

Chairperson

Ki Hoon Han (University of Ulsan, Korea)

11:25 - 12:05

Best approach to cardio & cerebrovascular health in the elderly

Hidenori Arai (National Center for Geriatrics and Gerontology, Japan)

September 17(Sat)
13:00 - 13:30
Plenary Lecture 6 (APSAVD:Yamamoto Lecture)
September 17(Sat) 13:00 - 13:30
Plenary Lecture 6 (APSAVD:Yamamoto Lecture)

Chairperson

Richard O’Brien (University of Melbourne, Australia)

13:00 - 13:30

Up close & personal with vascular diseases: the role of precision medicine

Maria Teresa Abola (University of Philippines, Philippines)

September 17(Sat)
13:35 - 14:35
Oral Presentation 4
September 17(Sat) 13:35 - 14:35
Oral Presentation 4

Chairperson

허경선 (충남대)

Panels

박세은(성균관의대), 서미혜(순천향의대)

13:35 - 13:42

Evaluation of the paradoxical association between lipid levels & incident atrial fibrillation according to statin usage: a nationwide cohort study 

안효정 (서울의대)

13:42 - 13:49

Comparison of cerebro-cardiovascular prognosis between cholesterol exposure estimate & cholesterol variability

주형준 (고려의대)

13:49 - 13:56

Early change in glucose level & risk of new-onset diabetes in patients initiating statin treatment

김충기 (이화의대)

13:56 - 14:03

Low-density lipoprotein cholesterol level, statin use & myocardial infarction risk in young adults

김미경 (가톨릭의대)

14:03 - 14:28

Q&A

September 17(Sat)
14:45 - 16:15
Symposium 20
How will new technologies change our research & patient care in ASCVD?
September 17(Sat) 14:45 - 16:15
Symposium 20
How will new technologies change our research & patient care in ASCVD?

Chairpersons

한승환 (가천의대), 김대중 (아주의대)

Panels

서용성 (명지병원), 황지원(인제의대)

14:45 - 15:05

Tips for performing nationwide big cohort studies

양필성 (차의대)

15:05 - 15:25

Advance of AI utility in past 5 years in ASCVD care: overview

조준환 (중앙의대)

15:25 - 15:45

Device-based care for CV risk factors

이학승 (메디컬에이아이)

15:45 - 16:10

Discussion

Breakfast & Luncheon Symposium
September 17(Sat)
08:00 - 09:00
Breakfast Symposium 3 [Yuhan]
September 17(Sat) 08:00 - 09:00
Breakfast Symposium 3 [Yuhan]

Chairperson

손태서 (가톨릭의대)

Panels

김정수 (부산의대), 전성완 (순천향의대)

08:00 - 08:20

A new paradigm of combination therapy in hypercholesterolemia treatment: rosuvastatin & ezetimibe

김병진 (성균관의대)

08:20 - 08:30

Discussion

September 17(Sat)
12:05 - 12:55
Luncheon Symposium 7 [Inno.N]
September 17(Sat) 12:05 - 12:55
Luncheon Symposium 7 [Inno.N]

Chairperson

이현철 (연세이현철내과)

Panels

박형복 (가톨릭관동대), 서미혜 (순천향의대)

12:05 - 12:25

Treatment of dyslipidemia with rosuvastatin & ezetimibe

김상현 (서울의대)

12:25 - 12:35

Discussion

September 17(Sat)
09:00 - 09:40
Plenary Lecture 4
September 17(Sat) 09:00 - 09:40
Plenary Lecture 4

Chairperson

Joong-Yeol Park (University of Ulsan, Korea)

09:00 - 09:40

New look at PCSK9 metabolism & its clinical implication

Sergio Fazio (Regeneron Pharmaceuticals, USA)

September 17(Sat)
09:45 - 11:15
Symposium 17
Emerging targets & drug platforms in dyslipidemia & atherosclerosis
September 17(Sat) 09:45 - 11:15
Symposium 17 Emerging targets & drug platforms in dyslipidemia & atherosclerosis

Chairpersons

Kyong Soo Park (Seoul National University, Korea), Alan Remaley (National Institute of Health, USA)

Panels

Gyuri Kim (Sunkyunkwan University, Korea), Chang-Hoon Woo (Yeungnam University, Korea)

09:45 - 10:05

Impact of lipases on human dyslipidemia & atherosclerosis

Hayato Tada (Kanazawa University, Japan)

10:05 - 10:25

Discover of new genes involved in low-density lipoprotein metabolism by genome-wide CRISPR-Cas9 screens

Alan Remaley (National Institutes of Health, USA)

10:25 - 10:45

Understanding strength & limitation of platforms in drug development

Dong Ki Lee (OliX Pharmaceuticals, Korea)

10:45 - 11:10

Discussion

September 17(Sat)
11:25 - 12:05
Plenary Lecture 5
September 17(Sat) 11:25 - 12:05
Plenary Lecture 5

Chairperson

Ki Hoon Han (University of Ulsan, Korea)

11:25 - 12:05

Best approach to cardio & cerebrovascular health in the elderly

Hidenori Arai (National Center for Geriatrics and Gerontology, Japan)

September 17(Sat)
13:00 - 13:30
Plenary Lecture 6 (APSAVD:Yamamoto Lecture)
September 17(Sat) 13:00 - 13:30
Plenary Lecture 6 (APSAVD:Yamamoto Lecture)

Chairperson

Richard O’Brien (University of Melbourne, Australia)

13:00 - 13:30

Up close & personal with vascular diseases: the role of precision medicine

Maria Teresa Abola (University of Philippines, Philippines)

September 17(Sat)
13:35 - 14:35
Oral Presentation 5
September 17(Sat) 13:35 - 14:35
Oral Presentation 5

Chairperson

Eun Seok Kang (Yonsei University, Korea)

Panels

Yong-ho Lee (Yonsei University, Korea), Ji-won Hwang (Inje University, Korea)

13:35 - 13:42

Ginsenoside Rh1 abolishes ROS-dependent KLF4 signaling pathway to inhibit proliferation & migration of vascular smooth muscle cells

Diem Thi Ngoc Huynh (Chungnam National University, Korea)

13:42 - 13:49

PCSK9 inhibitors inhibit monocyte adherence to stimulated human coronary artery endothelial cells

Rahayu Zulkapli (Universiti Teknologi MARA, Malaysia)

13:49 - 13:56

Lipoprotein(a) & cardiovascular & all-cause mortality in Korean adults

Byung Jin Kim (Sungkyunkwan University, Korea)

13:56 - 14:03

Saffron: a potential natural alternative remedy for statin intolerance

Iman Nabilah Abd Rahim (Universiti Teknologi MARA, Malaysia)

14:03 - 14:28

Q&A

September 17(Sat)
14:45 - 16:15
Symposium 21
New concepts in vascular biology
September 17(Sat) 14:45 - 16:15
Symposium 21 New concepts in vascular biology

Chairpersons

김치대 (부산대), 국현 (전남대)

Panels

진은선 (경희의대), 허진 (부산대)

14:45 - 15:05

What's new in vascular calcification in atherosclerosis?

이인규 (경북의대)

15:05 - 15:25

Senotherapeutics; a novel strategy for atherosclerosis

김재룡 (영남대)

15:25 - 15:45

Extracellular vesicles & endothelial cells

권기환 (이화의대)

15:45 - 16:10

Discussion

Breakfast & Luncheon Symposium
September 17(Sat)
08:00 - 09:00
Breakfast Symposium 4 [JW Pharmaceutical]
September 17(Sat) 08:00 - 09:00
Breakfast Symposium 4 [JW Pharmaceutical]

Chairperson

Ung Kim (Yeungnam University, Korea)

Panel

Kyung-Soo Kim (CHA University, Korea), Jae Hyuk Choi (Hallym University, Korea)

08:00 - 08:20

Management of poorly controlled patients with diabetes mellitus

Yongho Lee (Yonsei University, Korea)

08:20 - 08:30

Discussion

September 17(Sat)
12:05 - 12:55
Luncheon Symposium 8 [Hanmi]
September 17(Sat) 12:05 - 12:55
Luncheon Symposium 8 [Hanmi]

Chairperson

서홍석 (고려의대)

Panels

김병규 (인제의대), 조윤경 (울산의대)

12:05 - 12:25

Paradigm shift in dyslipidemia treatment (feat. RACING trial)

나승운 (고려의대)

12:25 - 12:35

Discussion

September 17(Sat)
09:00 - 09:40
Plenary Lecture 4
September 17(Sat) 09:00 - 09:40
Plenary Lecture 4

Chairperson

Joong-Yeol Park (University of Ulsan, Korea)

09:00 - 09:40

New look at PCSK9 metabolism & its clinical implication

Sergio Fazio (Regeneron Pharmaceuticals, USA)

September 17(Sat)
09:45 - 11:15
Symposium 18
Role & unsolved issues of novel lipid-modifying agents
September 17(Sat) 09:45 - 11:15
Symposium 18 Role & unsolved issues of novel lipid-modifying agents

Chairpersons

Byung Jin Kim (Sungkyunkwan University, Korea), Soo Lim (Seoul National University, Korea)

Panels

Min Kyong Moon (Seoul National University, Korea), Jang Hoon Lee (Kyungpook National University, Korea)

09:45 - 10:05

Challenges & perspective of drugs for Lp(a)

Gisette Reyes-Soffer (Columbia University, USA)

10:05 - 10:25

For whom & how much will bempedoic acid work?

Raul Santos (University of São Paulo, Brazil)

10:25 - 10:45

Recent trial results of new drugs targeting TG rich lipoprotein

Eun Ho Choo (The Catholic University of Korea, Korea)

10:45 - 11:10

Discussion

September 17(Sat)
11:25 - 12:05
Plenary Lecture 5
September 17(Sat) 11:25 - 12:05
Plenary Lecture 5

Chairperson

Ki Hoon Han (University of Ulsan, Korea)

11:25 - 12:05

Best approach to cardio & cerebrovascular health in the elderly

Hidenori Arai (National Center for Geriatrics and Gerontology, Japan)

September 17(Sat)
13:00 - 13:30
Plenary Lecture 6 (APSAVD:Yamamoto Lecture)
September 17(Sat) 13:00 - 13:30
Plenary Lecture 6 (APSAVD:Yamamoto Lecture)

Chairperson

Richard O’Brien (University of Melbourne, Australia)

13:00 - 13:30

Up close & personal with vascular diseases: the role of precision medicine

Maria Teresa Abola (University of Philippines, Philippines)

September 17(Sat)
14:45 - 16:15
Symposium 22 (TSLA/KSoLA Joint Symposium)
Sex difference in dyslipidemia & atherosclerosis
September 17(Sat) 14:45 - 16:15
Symposium 22 (TSLA/KSoLA Joint Symposium) Sex difference in dyslipidemia & atherosclerosis

Chairpersons

Sang-Hyun Kim (Seoul National University, Korea), Chul Sik Kim (Yonsei University, Korea)

Panels

Sung-Eun Kim (Hallym University, Korea), Sang Min Park (Eulji University, Korea)

14:45 - 15:05

Characteristics of dyslipidemia & ASCVD of women

Mi-Na Kim (Korea University, Korea)

15:05 - 15:25

Sex difference in diagnosis & treatment of ASCVD: what do we need to improve in women?

Ping-Yen Liu (National Cheng Kung University, Taiwan)

15:25 - 15:45

Is there difference of response to lipid-lowering therapy in women?

Chih-Fan Yeh (National Taiwan University, Taiwan)

15:45 - 16:10

Discussion

Breakfast & Luncheon Symposium
September 17(Sat)
12:05 - 12:55
Luncheon Symposium 9 [Amgen]
September 17(Sat) 12:05 - 12:55
Luncheon Symposium 9 [Amgen]

Chairperson

Kyong Soo Park (Seoul National University, Korea)

Panels

Eu Jeong Ku (Chungbuk National University, Korea), Choongki Kim (Ewha Womans University, Korea)

12:05 - 12:25

Key updates in the recent guidelines – identifying patients for evolocumab therapy

Wonjae Lee (Seoul National University, Korea)

12:25 - 12:35

Discussion

September 17(Sat)
09:45 - 11:15
Symposium 19
Current nutritional knowledge in cardiometabolic health
September 17(Sat) 09:45 - 11:15
Symposium 19 Current nutritional knowledge in cardiometabolic health

Chairpersons

Ji-Young Lee (University of Connecticut, USA), Kee Ho Song (Konkuk University, Korea)

Panels

In-Jeong Cho (Ewha Womans University, Korea), Jeong-Hwa Choi (Keimyung University, Korea)

09:45 - 10:05

Organ crosstalk under atherogenic diet

Cholsoon Jang (University of California Irvine, USA)

10:05 - 10:25

Emerging role of epigenetic regulation by nutrients in inflammation & atherosclerosis

Hyunju Kang (Keimyung University, Korea)

10:25 - 10:45

Transition to metabolically unhealthy status & cardiometabolic risks

Clara Yongjoo Park (Chonnam National University, Korea)

10:45 - 11:10

Discussion

September 17(Sat)
14:45 - 16:15
Symposium 23 (APSAVD Joint Symposium)
Update on antibodies & siRNA against PCSK9
September 17(Sat) 14:45 - 16:15
Symposium 23 (APSAVD Joint Symposium)
Update on antibodies & siRNA against PCSK9

Chairpersons

In-Kyung Jeong (Kyung Hee University, Korea), Hapizah Mohd Nawawi (Universiti Teknologi MARA, Malaysia)

Panels

Hyun Jae Kang (Seoul National University, Korea), Jong-Young Lee (Sungkyunkwan University, Korea)

14:45 - 15:05

Practical approach of PCSK9 Ab use in primary & secondary prevention

Young Joon Hong (Chonnam National University, Korea)

15:05 - 15:25

Comparison of two drug platforms for PCSK9 inhibition (Monoclonal antibodies & siRNA)

Richard O’Brien (University of Melbourne, Australia)

15:25 - 15:45

Patients who are resistant to or hypo-respond to PCSK9 inhibitors – a therapeutic challenge

Edward Janus (University of Melbourne, Australia)

15:45 - 16:10

Discussion

Breakfast & Luncheon Symposium
September 17(Sat)
12:05 - 12:55
Luncheon Symposium 10 [Sanofi]
September 17(Sat) 12:05 - 12:55
Luncheon Symposium 10 [Sanofi]

Chairperson

In-Kyu Lee (Kyungpook National University, Korea)

Panels

Jae Hyun Bae (Korea University, Korea), Sang-Hun Shin (Ewha Womans University, Korea)

12:05 - 12:25

The time for intensive LLT in very high-risk patients based on the updated Korean guideline

Hoyoun Won (Chung-Ang University, Korea)

12:25 - 12:35

Discussion

September 16(Fri)
13:35 - 14:15
Moderated Poster Presentation 3
September 16(Fri) 13:35 - 14:15
Moderated Poster Presentation 3

Chairperson

전성완(순천향의대)

Panels

김경수(차의대), 최한석(동국의대)

13:35 - 13:43

Autocrine regulation of cellular migration by secreted molecules from mechanically stressed vascular smooth muscle cells 

김주연 (부산대)

13:43 - 13:51

Depression & subclinical coronary atherosclerosis in adults without clinical coronary artery disease

박경민 (울산대)

13:51 - 13:59

Effect of lifestyle modification on the improvement of obesity, metabolic parameters & adipo-myokine related risk in overweight/obese adults

하미리 (동아대)

September 16(Fri)
13:35 - 14:15
Moderated Poster Presentation 4
September 16(Fri) 13:35 - 14:15
Moderated Poster Presentation 4

Chairperson

Su Yeon Choi (Seoul National University, Korea)

Panels

Hoyoun Won (Chung-Ang University, Korea), Kae Won Cho (Soonchunhyang University, Korea)

13:35 - 13:43

Mutation in CytB gene associated with macrophage intracellular lipid metabolism

Vasily Sukhorukov (Institute for Atherosclerosis Research, Russia)

13:43 - 13:51

Human milk oligosaccharides attenuate lipopolysaccharide-induced endothelial hyper-permeability & migration

Dung Van Nguyen (Chungnam National University, Korea)

13:51 - 13:59

Modeling of low-density lipoprotein desialylation processes in mice

Dmitry Kashirskikh (Petrovsky National Research Centre of Surgery, Russia)

13:59 - 14:07

Tyrosine Residues of mitochondrial creatine kinase mitigate hypoxia/reoxygenation injury in the heart through phosphorylation

Maria Victoria Faith Garcia (Cardiovascular and Metabolic Disease Center, Korea)

Sponsored by